U e p a r t m c n t o l I ' e d i d t r i i a , U l > i v c r i i t y u l Pornd,Redi~il S c l~o o 1 , l l A L Y e i i l h y r o l d c l t i l d r e n v i t l , C.II. on 1 -1 4 t r e d t m c n t . P d t l e n t a w e r e d i v i d e d i r~ t w u g r o u p s ( A -
D e s p i t e adequate replacement o f t h y r o i d hormone (TH), p a t i e n t s w i t h CH o f t e n e x h i b i t h i g h TSH l e v e l s . We i d e n t if i e d 16 c l i n i c a l l y e u t h y r o i d p a t i e n t s w i t h CH, 1.4-10 y e a r s o f age, whose t o t a l t h y r o x i n e (TT4) was 9.4-15.1 u g l d l (normal 5.0-12.2) o r f r e e Tq (FTq) was 1.6-2.2 n g / d l (normal 0.7-1.9), y e t whose TSH was 8-60 uIUIm1 (normal <4). Fourteen o f 16 had t h yr o i d a p l a s i a , compared t o 35% a p l a s i a i n CH. F i v e p a t i e n t s underwent a s h o r t TSH suppression t e s t : TH dose was doubled f o r 7 days, f o l l o w e d by d r u g w i t h d r a w a l and d a i l y d e t e r m i n a t i o n s o f TSH and TT4 o r FT4 f o r 10 days. F i v e p a t i e n t s underwent a l o n g supp r e s s i o n t e s t : TH dose was doubled f o r 7 days, f o l l o w e d by a r et u r n t o t h e p r e v i o u s dose and weekly d e t e r m i n a t i o n s o f hormones f o r 5 weeks. TSH t h r e s h o l d was d e f i n e d as t h e FT4 l e v e l when TSH i n c r e a s e d >4 uIU/ml. TSH t h r e s h o l d was 1.63k0.44 n g / d l FTq a f t e r suppression, compared t o >1.99+0.18 n g / d l FT b e f o r e suppression (p<0.005) and t o normal FT4 l e v e l s o f 1.3k0.2 n g / d l (p<0.001).
By s t a n d a r d i z a t i o n o f TSH t h r e s h o l d o n t o t h e c a l c u l a t e d TH dose, t h e o p t i m a l dose o f L -t h y r o x i n e was c a l c u l a t e d t o be 5.6k1.7 ug/ kg. Conclusions: 1 ) Severe h y p o t h y r o i d i s m i n t h e f e t u s and i nf a n t r e s u l t s i n h i g h TSH t h r e s h o l d s . 2 ) Suppression w i t h h i g hdose TH decreases TSH thresi!t,,~.
3 ) TSH suppression a l l o w s c a lc u l a t i o n o f o p t i m a l TH replacement. 4 ) TSH suppression i s recommended t o r e g a i n TSH l e v e l s as a means t o m o n i t o r t r e a t m e n t .
G.F.lZmcbnini,G.de Panlzza\A.Dolla2;",P.Beck-?eccoz"$,C.Chimllo D m t . of Tcdiat-irs, Endecrlile Unlt. I1 S.l?dfaele and (6) Dent. of J.M';ienpS;i, M . R a a t i k k a " , J . P a r t a n e n * a n d S.Koskimies:: D e p a r t m e n t o f P a e d i a t r i c s , A u r o r a H o s p i t a l , H e l s i n k i 176 a n d F i n n i s h Red C r o s s B l o o d T r a n s f u s i o n S e r v i c e , H e ls i n k i , F i n l a n d . JUVENILE AUTOIMMUNE THYROIDITIS ( J A l T ) IS ASSOCIATED WITH HLA-DR4.
T h e a s s o c i a t i o n s o f H a s h i m o t o ' s g o i t r o u s t h y r o i d i t i s w i t h HLA-DR5, a t r o p h i c t h y r o i d i t i s w i t h DR3, p o s t p a r t u m t h y r o i d i t i s w i t h DR4 a n d G r a v e ' s d i s e a s e w i t h DR3 h a v e b e e n d e s c r i b e d . We s t u d i e d
HLA-A,B,C,DR a n t i g e n s , C4 a n d B f t y p e s a n d t h y r o i d f u n c t i o n i n 64 p a t i e n t s w i t h J A I T . 4 5 o f t h e m w e r e y o u n g a d u l t s w i t h a mean f o l l o w -u p o f 1 0 . 6 y e a r s ( J P e d i a t r 1 9 8 5 ; 1 0 7 : 8 9 8 ) , o t h e r s w e r e 9 . 6 -1 7 . 5 y e a r s o f a g e a n d w e r e f o l l o w e d f o r 2 . 3 ( 0 . 5 -8 . 5 ) y e a r s . T h e HLA-DR a n t i a e n f r e q u e n c i e s i n p a t i e n t s ( a n d c o n t r o l s ) w e r e : DR1 2 0 % ( 3 7 2 ) P < 0 . 0 1 , DR2 2 4 % ( 3 3 % ) , DR3 3 2 % ( 3 2 % ) , DR4 5 4 % ( 2 7 % ) P < 0 . 0 0 1 , DR5 3 % ( 6 % ) , DR6 10% ( 5 % ) , DR7 14% ( 1 7 % ) a n d DR8 3% ( 1 3 % ) P < 0 . 0
i e n t s . C i r c~~l a t i n g a n t i m i c r o s o m a 1 a n t i b o d i e s (~s a b ) ( t i t r e > 4 0 0 ) w e r e p r e s e n t i n 7 3 % a n d a n t i t h y r o g l o b u l i n a n t i b o d i e s T t i t r e 2 4 0 0 ) i n 3 8 % . Of t h e 1 7 p a t i e n t s w i t h a b s e n t o r low t i tr e Msab 16 w e r e e u t h y r o i d ( P < 0 . 0 0 1 ) a n d 1 3 o f t h e m w e r e DR4 p o s i t i v e ( P < 0 . 0 5 ) .
C o n c l u s i o n : J A I T i s h i g h l y s i g n i f i c a n t l y a s s o c i a t e d w i t h HLA-DR4 a n d e u t h y r o i d i s m w i t h a b s e n t o r low Msab t i t r e . 
FAMILIAL HYPERTHYROIDISM DUE TO INAPPROPRIATE TSH SECRETION:
A SEX LINKED DOMINANT TRAIT Studies in 2 non-related Sephardic Jewish lamilies, one of which extended over 5 generations, revealed 9 females with clinical and/or biochemical hyperthyroidism due to inappropriate TSH secretion. Age at diagnosis ranged lrom early infancy up to 80 years, the youngest case being detected by measuring elevated thyroid hormones and TSH on a lilter paper specimen obtained lor routine screening for neonatal hypothyroldism. Except in one c a s e . the clinical manifestations became apparent at adolescence and were more severe in older patients than in younger ones. Yet, these were in general milder than those found in classical Grave's disease. In 4 instances the disorder was diagnosed when symptoms recurred after subtotal thyroldectomy. None had a pituitary tumor. All subjects had elevated levels 01 thyroid hormones and prolactin (T4: 14-22 ug/dl, T3: 220-320 ng/dl. T3 Uptake: 4 1-65 2 . TSH: 5 -2 6 uU/ml. prolactin: 15-75 ng/ml). TRH lurther stimulated TSH and prolactin, resembling the response in hypothyroidism. T3 (25 ug/tid) given lor one week reduced T4 . T3 and TSH (measured 16 h after the Inw dose), but T4 (given in equimolar amounts in 2 patients) did not supress any 01 these parameters. Long term therapy with asingle AM dose 01 T3 (25-50 ug) was given to 6 symptomatic patients. All became clinically and biochemically euthyroid after 3-4 months of therapy, and remained normal since then (up to 7 years). Inappropriate TSH secretion seems to be due to partial unresponsiveness 01 the thyrotroph to thyroid hormones. The delect may reside in a delicient pituitary T4 monodeiodinase (resulting in low intracellular T3 levels) or in a thyrotroph which has reduced sensitivity to T3.
Genetic analysis reveals that X-linked dominance i s the most likely mode of inheritance. Calculation of thevariance of the expectancy (by the Fisher Exact Test) was highly signilicant (p-<0.015), indicating that the exclusive prevalence of the mutant gene in lemales does not occur at random. Since ' TUl deficiency a c c o u i~; So; . c l l r r l c f i and b i e c h a n i w l p i c i w e o f Tliii, 'dip e t i o l q l d 'dierqxu'iic il[~,mx~ch to 'dils rare dlsezse should b e l'liil achilnrst-aLiar. Aficr liifo~~lhld conseni f m l i parenis, we achinlnlsJared TI31 p.o. Lo 3 potlcriis with ;Ill: a~ t h e dose o f ZJ r,g/chy f o r 25 days and ;hen 10 i g . every o i i~e r day €01-3 mri'd?. in o~l l e r ' LC a v o~d 'die v i e l l -l m a~~ p h e m m o n o f p i t u~t a -y <icscnsitizatlmr. Durirg ihc ;int p w i d a l l paiienL6 shm~ed a m-ked lncrease I n 1511 secretla?, i!hen ircni'kred 3 h~. a f t e r 1 x 1 a&,~lnlsiraLion (basal: 4.1, 5.9,and 27.2; peak: 16.4, 1G.3 and 69.7 mcU/n1, ~r s p~x l i v e l y ) .
Consmluently, iT3 m d FT4 l e v e l s increased, ? , a c h i n g iite n o d range a i d i f f e r c n i in'ervals; only m one p a t i e n t kT3 and I,.?o values were 111 Ll~e n o m l v e over all the t l -e a k n t period. After TRJl r,iihdn~ a l basal h o m n c l e v e l s f e l l to prekca'mcn'i v a l~l c s v~~t h :ire exception of TSH whlcli consisienily lower (0.9, 1.1 ;rid 6.3 mcU/i:L, ~.cr;pectively), thus d m o~i s a ' i~n g : I p l t u i '~ dcsensitluiitlon. D u r i n g the sccorid purl& a l l patiellis had a n increase I n Ell l e v e l s b u t a l l y i n m e case a slrjLzlned nonmllu'ilon o f FT4 l e v e l s was seen. ilo s i d e effeeLfi were noL&. i n conclislon, t h e present daia. 1) c m f r m that '1TUl a s d a l l y therapy rffi'arcs a 'il-amlent eu;iiy~u1d stace i n p a t i e n t s vn'h IHI; 2) danons'irae t h a t , a~ t h e dose and t i a e schedule iue used, la&--tern 'I'M1 a h i n i s P a t i o n d m n o t s e a effective i n t h e t r c a ' m ' i o r IMI, bcwuse of p i i u ' m y desemlirr/a;ion; and 3) s u g e s t that L-'i'tly~uxinc rcplacanent ii,crq?y s t r l l I-amlns t h e I=' L i.cllable urc3'jient o f i h l s disease.
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